AU2002309931A1 - Method for enriching tissues in long chain polyunsaturated fatty acids - Google Patents

Method for enriching tissues in long chain polyunsaturated fatty acids

Info

Publication number
AU2002309931A1
AU2002309931A1 AU2002309931A AU2002309931A AU2002309931A1 AU 2002309931 A1 AU2002309931 A1 AU 2002309931A1 AU 2002309931 A AU2002309931 A AU 2002309931A AU 2002309931 A AU2002309931 A AU 2002309931A AU 2002309931 A1 AU2002309931 A1 AU 2002309931A1
Authority
AU
Australia
Prior art keywords
enriching
tissues
fatty acids
long chain
polyunsaturated fatty
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Abandoned
Application number
AU2002309931A
Other languages
English (en)
Inventor
Marc E. Surette
Kenneth M. Tramposch
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Pilot Therapeutics Inc
Original Assignee
Pilot Therapeutics Inc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Pilot Therapeutics Inc filed Critical Pilot Therapeutics Inc
Publication of AU2002309931A1 publication Critical patent/AU2002309931A1/en
Abandoned legal-status Critical Current

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/185—Acids; Anhydrides, halides or salts thereof, e.g. sulfur acids, imidic, hydrazonic or hydroximic acids
    • A61K31/19—Carboxylic acids, e.g. valproic acid
    • A61K31/20—Carboxylic acids, e.g. valproic acid having a carboxyl group bound to a chain of seven or more carbon atoms, e.g. stearic, palmitic, arachidic acids
    • A61K31/201—Carboxylic acids, e.g. valproic acid having a carboxyl group bound to a chain of seven or more carbon atoms, e.g. stearic, palmitic, arachidic acids having one or two double bonds, e.g. oleic, linoleic acids
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/185—Acids; Anhydrides, halides or salts thereof, e.g. sulfur acids, imidic, hydrazonic or hydroximic acids
    • A61K31/19—Carboxylic acids, e.g. valproic acid
    • A61K31/20—Carboxylic acids, e.g. valproic acid having a carboxyl group bound to a chain of seven or more carbon atoms, e.g. stearic, palmitic, arachidic acids
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/185—Acids; Anhydrides, halides or salts thereof, e.g. sulfur acids, imidic, hydrazonic or hydroximic acids
    • A61K31/19—Carboxylic acids, e.g. valproic acid
    • A61K31/20—Carboxylic acids, e.g. valproic acid having a carboxyl group bound to a chain of seven or more carbon atoms, e.g. stearic, palmitic, arachidic acids
    • A61K31/202—Carboxylic acids, e.g. valproic acid having a carboxyl group bound to a chain of seven or more carbon atoms, e.g. stearic, palmitic, arachidic acids having three or more double bonds, e.g. linolenic
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
    • A61K36/02—Algae
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
    • A61K36/02—Algae
    • A61K36/03—Phaeophycota or phaeophyta (brown algae), e.g. Fucus
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
    • A61K36/18—Magnoliophyta (angiosperms)
    • A61K36/185—Magnoliopsida (dicotyledons)
    • A61K36/30—Boraginaceae (Borage family), e.g. comfrey, lungwort or forget-me-not
    • Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y02—TECHNOLOGIES OR APPLICATIONS FOR MITIGATION OR ADAPTATION AGAINST CLIMATE CHANGE
    • Y02A—TECHNOLOGIES FOR ADAPTATION TO CLIMATE CHANGE
    • Y02A50/00—TECHNOLOGIES FOR ADAPTATION TO CLIMATE CHANGE in human health protection, e.g. against extreme weather
    • Y02A50/30—Against vector-borne diseases, e.g. mosquito-borne, fly-borne, tick-borne or waterborne diseases whose impact is exacerbated by climate change

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Natural Medicines & Medicinal Plants (AREA)
  • Epidemiology (AREA)
  • Engineering & Computer Science (AREA)
  • Medicinal Chemistry (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Biotechnology (AREA)
  • Chemical & Material Sciences (AREA)
  • Alternative & Traditional Medicine (AREA)
  • Botany (AREA)
  • Medical Informatics (AREA)
  • Microbiology (AREA)
  • Mycology (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
AU2002309931A 2001-05-17 2002-05-17 Method for enriching tissues in long chain polyunsaturated fatty acids Abandoned AU2002309931A1 (en)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
US29158401P 2001-05-17 2001-05-17
US60/291,584 2001-05-17
PCT/US2002/015747 WO2002092779A2 (fr) 2001-05-17 2002-05-17 Procede d'enrichissement de tissus dans des acides gras polyinsatures a chaine longue

Publications (1)

Publication Number Publication Date
AU2002309931A1 true AU2002309931A1 (en) 2002-11-25

Family

ID=23120911

Family Applications (1)

Application Number Title Priority Date Filing Date
AU2002309931A Abandoned AU2002309931A1 (en) 2001-05-17 2002-05-17 Method for enriching tissues in long chain polyunsaturated fatty acids

Country Status (2)

Country Link
AU (1) AU2002309931A1 (fr)
WO (1) WO2002092779A2 (fr)

Families Citing this family (10)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO2003075670A1 (fr) * 2002-03-08 2003-09-18 Monsanto Technology Llc Traitement et prevention de troubles inflammatoires
AU2005304994B2 (en) 2004-11-04 2011-12-08 Monsanto Technology Llc High PUFA oil compositions
WO2007066216A2 (fr) * 2005-12-09 2007-06-14 Institut National De La Sante Et De La Recherche Medicale (Inserm) Profils des acides gras correles a la tendance naturelle ou au risque de cancer du sein
JP2009529044A (ja) * 2006-03-03 2009-08-13 モンサント テクノロジー エルエルシー 心臓血管健康を改善するための手段
ES2540910T3 (es) 2006-03-14 2015-07-14 Oilseeds Biorefinery Corporation Extracción de aceite usando ésteres alquílicos de ácidos grasos
ES2541911T3 (es) 2006-06-08 2015-07-28 Iams Europe B.V. Uso de al menos un polifenol para estimular la salud ocular
US20090197955A1 (en) * 2008-01-31 2009-08-06 Monsanto Company Methods of improving dha deposition and related function and/or development
JP2012514596A (ja) * 2009-01-05 2012-06-28 カラナス エーエス バイオオイル組成物、上記オイル組成物を含む製剤と、循環器疾患の予防又は治療のためのその使用
KR101938055B1 (ko) 2017-04-05 2019-01-14 성균관대학교산학협력단 개꼬시래기 추출물 또는 분획물을 유효성분으로 함유하는 동맥경화증의 예방 및 치료용 약학 조성물
CN107095953A (zh) * 2017-06-12 2017-08-29 张伟伟 一种治疗妊娠抑郁的中药

Family Cites Families (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB9012651D0 (en) * 1990-06-06 1990-07-25 Efamol Holdings Essential fatty acid treatment
ATE236627T1 (de) * 1996-10-11 2003-04-15 Scarista Ltd Pharmazeutische zubereitung enhaltend eicosapentaensäure und/oder stearidonsäure
DE19757414A1 (de) * 1997-12-23 1999-07-01 Nutricia Nv Fettmischung
US6107334A (en) * 1998-02-23 2000-08-22 Wake Forest University Dietary control of arachidonic acid metabolism
US6340705B1 (en) * 1999-09-10 2002-01-22 Monsanto Technology, Llc Use of α-linolenic acid metabolites for treatment or prevention of cancer

Also Published As

Publication number Publication date
WO2002092779A3 (fr) 2003-03-13
WO2002092779A2 (fr) 2002-11-21

Similar Documents

Publication Publication Date Title
PT2172536T (pt) Processo para a produção de ácidos gordos poli-insaturados em organismos transgénicos
EP1682567A4 (fr) Desaturases delta12 pouvant etre utilisees pour modifier les niveaux d'acides gras polyinsatures dans une levure oleagineuse
AU4564399A (en) Polyunsaturated fatty acids in plants
AU2005217079B9 (en) Method for producing polyunsaturated fatty acids in transgenic plants
IL218358A0 (en) Method for the production of polyunsaturated fatty acids
AU2012244304A1 (en) Novel plant acyltransferases specific for long-chain polyunsaturated fatty acids
AU2012244303A1 (en) Novel plant acyltransferases specific for long-chain polyunsaturated fatty acids
AU2001239244A1 (en) Novel elongase gene and method for producing multiple-unsaturated fatty acids
EP1157707B8 (fr) Composition et procédé pour la déformation de tissus mous
AU2003281542A1 (en) Preparation of microbial oil containing polyunsaturated fatty acids
AU2003206714A1 (en) Elongase gene and method for producing polyunsaturated fatty acids
AU2002309931A1 (en) Method for enriching tissues in long chain polyunsaturated fatty acids
AU2003258496A1 (en) Method for the production of conjugated polyunsaturated fatty acids comprising at least two double bonds in plants
AU2003222739A1 (en) A facile two-step enzyme process for increasing the content of polyunsaturated fatty acids in fish oil
AU2003287584A1 (en) Conjugated fatty acid based emulsion and methods for preparing and using same
AU2003222837A1 (en) Method for producing conjugated linoleic acid glycerides
AU2002258505A1 (en) Compositions and methods for modifying the content of polyunsaturated fatty acids in mammalian cells
AU2299400A (en) Method for expoxidizing or dihydroxilating unsaturated fatty acids
AU2003229744A1 (en) Method for producing c4-c12 fatty acids
IL160818A0 (en) Method for producing 3-bromomethylbenzoic acids
AU2002329230A1 (en) Method for producing arachidonic acid in transgenic organisms
AU2001295991A1 (en) Compositions for improving lipids in blood
AU2001248333A1 (en) Method and composition for skin lightening applying carboxylic acids
PL377835A1 (pl) Sposób wytwarzania ß-estru Ó-L-aspartylo-L-fenyloalaninowego i sposób wytwarzania estru Ó-L-aspartylo-L-fenyloalanino- Ó-metylowego
AU2003293020A1 (en) Method and composition with conjugated linoleic acid esters

Legal Events

Date Code Title Description
MK6 Application lapsed section 142(2)(f)/reg. 8.3(3) - pct applic. not entering national phase